OneWorld Health Named One of the Top 100 NGOs
OneWorld Health (OWH) was included in The Global Journal’s inaugural ‘Top 100 Best NGOs’ list last week! We entered this first international ranking of its kind at #65.
The Journal emphasized that OWH was created to address inequality gaps in medical treatments for diseases that receive limited investments, yet profoundly affect people living in developing countries. It also spotlighted the product development partnership (PDP) nature of OWH, which allows this drug development non-profit to reach its goals efficiently and cost-effectively.
“We have made a lot of progress in our efforts to fulfill the promise of medicine for people of the developing world,” said Hugh Chang, OWH’s Interim CEO. “Our project to produce semi-synthetic artemisinin will make it possible for this compound to reach greater number of malaria patients; our pioneering treatment for kala-azar (visceral leishmaniasis) has been expanded to more areas than ever; and our efforts to develop a new drug to treat secretory diarrhea are moving closer to phase 2 clinical trials. We are grateful for having our work and our innovative spirit recognized by The Global Journal.”
About OneWorld Health
OneWorld Health discovers, develops, and delivers safe, effective, and affordable new treatments for neglected infectious diseases afflicting children in the developing world. For more information, please visit www.oneworldhealth.org.
OneWorld Health is an affiliate of PATH, an international nonprofit organization that transforms global health through innovation. To learn more about PATH, visit www.path.org.
AboutThe Global Journal
The Global Journal is a print and online publication based in Geneva and New York that covers the issues and players shaping global governance today. Committed to providing compelling and insightful content distinguished by the highest journalistic standards, The Global Journal features exclusive interviews with key players, covers current debates and thought-provoking ideas, and offers in- depth reports and compelling images to a growing international audience.